NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Call Transcript February 22, 2024 NovoCure Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to the NovoCure Q4 2023 Earnings Conference Call. At this […]
Operator: Good day and thank you for standing by. Welcome to the NovoCure Q4 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript February 21, 2024 Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.39. LUNG isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]